Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study
- PMID: 36034561
- PMCID: PMC9403004
- DOI: 10.3389/fped.2022.917731
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study
Abstract
Background: Children with juvenile idiopathic arthritis (JIA) might be at a higher risk of infection. Our objectives are to describe and compare infection rates in patients with JIA vs. healthy patients.
Methods: A prospective, multicenter observational study was performed in Spain from January 2017 to June 2019. Patients with JIA from 7 participating hospitals and children without JIA (siblings of patients with JIA, and non-JIA children from primary health centers) were followed up with quarterly questionnaires to record infection episodes. Tuberculosis, herpes zoster, and infections requiring hospital admission were considered severe infections. Rates of infection (episodes/patient/year) were compared using a generalized estimating equations model.
Results: A total of 371 children (181 with and 190 without JIA) were included. The median age was 8.8 years (IQR 5.5-11.3); 75% of the patients with JIA received immunosuppressive treatment (24% methotrexate, 22% biologic, 26% both). A total of 667 infections were recorded; 15 (2.2%) were considered severe. The infection rate was 1.31 (95%CI 1.1-1.5) in JIA and 1.12 (95%CI 0.9-1.3) in non-JIA participants (p = 0.19). Age <4 years increased the infection rate by 2.5 times (2.72 vs. 1.12, p < 0.001) in both groups. The most frequent infection sites were upper respiratory (62.6% vs. 74.5%) and gastrointestinal (18.8% vs. 11.4%). There were no differences in severe infections (2.5% vs. 2%, p = 0.65) between the groups. In children with JIA, younger age and higher disease activity (JADAS71) were associated with a higher infection rate.
Conclusion: We found no differences in the infection rate or infection severity between patients with and without JIA. Most infections were mild. An age younger than 4 years increased the infection risk in both groups. Higher disease activity was associated with a higher infection rate.
Keywords: infection rate; infections; juvenile idiopathic arthritis (JIA); methotrexate; safety; tumor necrosis alpha antagonist.
Copyright © 2022 Udaondo, Núñez Cuadros, Murias, Remesal, Alcobendas, Guerrero, Guillen-Martin, Escuredo, Aleo, Alonso, Tagarro, De Santiago, Camacho-Lovillo, Diaz, Arenas, Camacho, Lirola, Díaz Almirón and Calvo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Toussi SS, Pan N, Walters HM, Walsh TJ. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: Systematic review of the literature. Clin Infect Dis. (2013) 57:1318–30. 10.1093/cid/cit489 - DOI - PMC - PubMed
-
- Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: Combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. (2018) 20:285. 10.1186/s13075-018-1780-z - DOI - PMC - PubMed
